1Ferret I, Santpere G, van Leeuwen FW. Argyrophilic grain disease. Brain, 2008 ; 131 ( 6 ) : 1416.
2Botez G, Probst A, Ipsen S,et al. Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease. Acta Neuropathol, 1999 ;98 (3) :251.
3Tolnay M, Calhoun M, Pham HC,et al. Low amyloid (A[3) plaque load and relative predominance of diffuse plaques distinguish argyrophilic grain disease from Alzheimer's disease. Neuropathol Appl Neurobiol, 1999 ;25 (4) :295.
4Braak H, Braak E. Argyrophilic grain disease : frequency of occurrence in different age categories and neuropathological diagnostic criteria. J Neural Transm, 1998;105(8 -9) :801.
7Tolnay M, Clavaguera F. Argyrophilic grain disease: a late- onset dementia with distinctive features among tauopathies. Neuropathology, 2004;24(4) :269.
8Thai DR, Schuhz C, Botez G,et al. The impact of argyrophilic grain disease on the development of dementia and its relationship to concurrent Alzheimer's disease - related pathology. Neuropathol Appl Neurobiol, 2005 ;31 (3) :270.
9Togo T, Cookson N, Dickson DW. Argyrophilic grain disease : neuropathology, frequency in a dementia brain bank and lack of relationship with apolipoprotein E. Brain Pathol, 2002 ; 12 ( 1 ) :45.
1Lowe J. Establishing a pathological diagnosis in degenerative dementias. Brain Pathol,1998,8:403-406.
2Munoz DG. Stains for the differential diagnosis of degenerative dementias. Biotech Histochem, 1999, 76: 311-320.
3Markesbery WR.Neuropathological criteria for the diagnosis of Alzheimer′s disease. Neurobiol Aging, 1997,18(4 Suppl):S13-S19.
4McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies(DLB): report of the consortium on DLB international workshop. Neurology,1996,47:1113-1124.
5Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol, 1996,55:97-105.
6Dickson DW, Bergeron C, Chin SS, et al. Office of Rare Diseases neuropathlogic criteria for corticobasal degeneration. J Neuropathol Exp Neurol, 2002,61:935-946.
7McKhann GM, Albert MS, Grossman M, et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick′s Disease. Arch Neurol, 2001,58:1803-1809.
8Dickson DW. Tau and synuclein and their role in neuropathology. Brain Pathol,1999,9:657-661.
9Cooper PN, Jackson M, Lennox G, et al. Tau, ubiquitin, and alpha B-crystallin immunohistochemistry define the principal causes of degenerative frontotemporal dementia. Arch Neurol, 1995,52:1011-1015.
